PolyA RNA-seq from retinoic acid-differentiated iPSCs treated with GSK343, 5-aza, or Combo (GSK343 & 5-aza)
Ontology highlight
ABSTRACT: Analysis of steady-state mRNA levels in induced pluripotent stem cells (iPSCs) differentiated for 5 days with retinoic acid (RA) and treated for final 48 hrs with GSK343 (EZH2 inhibitor), 5-azacytidine (5-aza, DNA methyltransferase inhibitor), or their combination (Combo).
ORGANISM(S): Homo sapiens
PROVIDER: GSE207375 | GEO | 2022/11/08
REPOSITORIES: GEO
ACCESS DATA